Hyaluronidase and rituximab
Generic name: Hyaluronidase And Rituximab
Brand names: Rituxan Hycela
Dosage form: subcutaneous solution (23,400 units-1400 mg/11.7 mL; 26,800 units-1600 mg/13.4 mL)
Drug class:
CD20 monoclonal antibodies
Usage of Hyaluronidase and rituximab
Hyaluronidase and rituximab is a combination medicine used to treat follicular lymphoma, diffuse large B-cell lymphoma, or chronic lymphocytic leukemia.
Hyaluronidase and rituximab is sometimes used together with other cancer medicines.
This combination medicine is usually given only after you have received at least 1 injection of rituximab alone.
Hyaluronidase and rituximab may also be used for purposes not listed in this medication guide.
Hyaluronidase and rituximab side effects
Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).
Some side effects may occur during the injection (or within 24 hours afterward). Tell your caregiver right away if you feel itchy, dizzy, weak, light-headed, short of breath, chilled, feverish, or if you have chest pain, wheezing, a sudden cough, or pounding heartbeats or fluttering in your chest.
Rituximab may cause a serious brain infection that can lead to disability or death. Call your doctor right away if you have problems with speech, thought, vision, or muscle movement.
Serious and sometimes fatal infections may occur during treatment with hyaluronidase and rituximab. Call your doctor right away if you have signs of infection such as:
Call your doctor at once if you have any of these other side effects, even if they occur several months after your last dose of hyaluronidase and rituximab:
Common side effects of hyaluronidase and rituximab may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Hyaluronidase and rituximab
Tell your doctor if you have ever had:
Rituximab may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 12 months after your last dose. Tell your doctor if you become pregnant.
Do not breastfeed while using this medicine, and for at least 6 months after your last dose.
Relate drugs
- Columvi
- Briumvi
- Epcoritamab-bysp
- Epkinly
- Gazyva
- Glofitamab-gxbm
- Hyaluronidase and rituximab
- Obinutuzumab
- Ocrelizumab
- Ocrevus
- Riabni
- Riabni (Rituximab Intravenous)
- Riabni (Rituximab-arrx Intravenous)
- Rituxan Hycela
- Rituximab and hyaluronidase human, recombinant
- Ruxience
- Ruxience (Rituximab Intravenous)
- Ruxience (Rituximab-pvvr Intravenous)
- Truxima
- Truxima (Rituximab Intravenous)
- Truxima (Rituximab-abbs Intravenous)
- Ublituximab
- Ublituximab-xiiy
How to use Hyaluronidase and rituximab
Hyaluronidase and rituximab is injected under the skin of your stomach area. hyaluronidase and rituximab must be injected slowly over 5 to 7 minutes. A healthcare provider will give you this injection.
You will be watched closely for at least 15 minutes after receiving hyaluronidase and rituximab, to make sure you do not have an allergic reaction.
Before each injection, you may be given other medicine to prevent certain side effects. Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
If you have chronic lymphocytic leukemia, you may also need to take medicine to prevent infections. You may need to keep taking this medicine for up to 12 months after your last dose of hyaluronidase and rituximab.
Hyaluronidase and rituximab can lower blood cells that help your body fight infections. Your blood will need to be tested often.
If you've ever had hepatitis B, using rituximab can cause this virus to become active or get worse. You may need frequent liver function tests while using this medicine and for several months after you stop.
Warnings
Do not use if you are pregnant. Avoid getting pregnant for at least 12 months after you stop using hyaluronidase and rituximab.
Rituximab may cause a serious brain infection that can lead to disability or death. Call your doctor right away if you have problems with speech, thought, vision, or muscle movement.
If you've ever had hepatitis B, using rituximab can cause this virus to become active or get worse.
Severe skin problems can also occur during treatment with rituximab. Call your doctor if you have painful skin or mouth sores, or a severe skin rash with blistering, peeling, or pus.
Some side effects may occur during the injection or within 24 hours afterward. Tell your caregiver right away if you feel itchy, dizzy, weak, light-headed, short of breath, chilled, feverish, or if you have chest pain, wheezing, a sudden cough, or pounding heartbeats or fluttering in your chest.
What other drugs will affect Hyaluronidase and rituximab
Other drugs may affect hyaluronidase and rituximab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions